9月17日港股创新药ETF鹏华（159286）份额减少1000.00万份

Core Viewpoint - The Hong Kong Innovative Drug ETF managed by Penghua experienced a slight decline of 0.30% on September 17, with a trading volume of 98.91 million yuan and a reduction of 10 million shares, bringing the total shares to 534 million [1] Group 1: Fund Performance - The latest net asset value of the Hong Kong Innovative Drug ETF is 543 million yuan [1] - Since its establishment on August 20, 2025, the fund has achieved a return of 1.77% [1] Group 2: Management Information - The fund is managed by Penghua Fund Management Co., Ltd., with fund managers Lin Song and Zhang Yuxiang [1] - The performance benchmark for the fund is the National Index of Hong Kong Stock Connect Innovative Drug Index, adjusted for exchange rates [1]